blindTopic
검색
Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024
May 21, 2024 11:00 ET| Source: Mobile-health Network SolutionsFollow
SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced that for the first six months of fiscal 2024 (“H1FY24”) ended December 31, 2023, the Company had revenue of approximately $6.6 million, approximately a 120% improvement on revenue of $3.0 million for the same period in fiscal 2023 (“H1FY23”).
Telemedicine consultations on the platform increased by approximately 101% during H1FY24, reaching 731,000 compared to 363,000 during H1FY23. The Company believes that this growth was driven by both increased adoption rates and a larger market share. Coupled with the implementation of a dynamic pricing model which increased the average consultation fees, the revenue grew by approximately 120% between H1FY23 and H1FY24. Additionally, the Company improved workflow efficiency for medical professionals by introducing enhancements to the native application, allowing them to focus on core clinical tasks.
The Company’s gross profit increased by approximately $0.8 million, or 218% to $1.2 million during H1FY24, mainly due to the 120% increase in revenue and the increase in gross profit margin from 12.7% during H1FY23 to 18.2% during H1FY24.
The Company expanded its headcount and expenses to meet increased operational demand and explore new market opportunities, resulting in an increase in net loss of $171,634 during H1FY24 as compared to H1FY23.
Cash and cash equivalents at December 31, 2023, and June 30, 2023, was approximately $2.5 million and $2.2 million, respectively.
All of the above financial results and data are for the period prior to the Company’s initial public offering on April 10, 2024.
“Our H1FY24 results is an encouraging endorsement to our vision of providing an affordable, near-instantaneous quality care to our patients,” said co-CEO, Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician. “Going forward, we will continue to work hard to scale and extend this vision beyond the Singapore’s shore, and eventually a better future for our children.”
댓글 7
LG화학 · ×***
스캠주식글은 왜 퍼다 나르는거
HL클레무브 · M****
니 메모장에 써
SK텔레콤 · 키***** 작성자
차트는 바닥에 2022 2023 보다 성장이 훨 더 가속화 되었기에... 관심권
LG화학 · ×***
옘병하네 진짜 ㅋㅋㅋ 너 개처물려서 물귀신 작전하는거잖아. 너나 많이 사세요
SK텔레콤 · 키***** 작성자
말그대로 관심권. 또 성장해 성장이 훼손되지 않으면 매입해도 될 자리. AI원격의료는 빅테크 관심 분야
새회사 · i*********
와 마블헬스케어 쩐다….
SK텔레콤 · 키***** 작성자
AI 원격 의료 헬스 피부 미용 제약 분야는 빅테크 및 국내 기업의 주요 관심분야로 투자시 날라갈 수 있기에... 관심권...